1. Insight into the genetics of diabetic nephropathy through the study of mice. Breyer MD, Qi Z, Tchekneva EE, Harris RC (2008) Curr Opin Nephrol Hypertens 17(1): 82-6
    › Primary publication · 18090675 (PubMed)
  2. Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors. Chen JK, Chen J, Imig JD, Wei S, Hachey DL, Guthi JS, Falck JR, Capdevila JH, Harris RC (2008) J Biol Chem 283(36): 24514-24
    › Primary publication · 18606824 (PubMed) · PMC2528993 (PubMed Central)
  3. Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Pozzi A, Jarad G, Moeckel GW, Coffa S, Zhang X, Gewin L, Eremina V, Hudson BG, Borza DB, Harris RC, Holzman LB, Phillips CL, Fassler R, Quaggin SE, Miner JH, Zent R (2008) Dev Biol 316(2): 288-301
    › Primary publication · 18328474 (PubMed) · PMC2396524 (PubMed Central)
  4. Apoptosis of the thick ascending limb results in acute kidney injury. Srichai MB, Hao C, Davis L, Golovin A, Zhao M, Moeckel G, Dunn S, Bulus N, Harris RC, Zent R, Breyer MD (2008) J Am Soc Nephrol 19(8): 1538-46
    › Primary publication · 18495962 (PubMed) · PMC2488270 (PubMed Central)
  5. An update on cyclooxygenase-2 expression and metabolites in the kidney. Harris RC (2008) Curr Opin Nephrol Hypertens 17(1): 64-9
    › Primary publication · 18090672 (PubMed)
  6. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. Jo YI, Cheng H, Wang S, Moeckel GW, Harris RC (2007) Nephron Exp Nephrol 107(3): e87-94
    › Primary publication · 17890881 (PubMed)
  7. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. Cheng H, Wang S, Jo YI, Hao CM, Zhang M, Fan X, Kennedy C, Breyer MD, Moeckel GW, Harris RC (2007) J Am Soc Nephrol 18(2): 551-9
    › Primary publication · 17202413 (PubMed)
  8. Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite. Chen J, Chen JK, Falck JR, Guthi JS, Anjaiah S, Capdevila JH, Harris RC (2007) Mol Cell Biol 27(8): 3023-34
    › Primary publication · 17283047 (PubMed) · PMC1899952 (PubMed Central)
  9. Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype. Singh AB, Sugimoto K, Harris RC (2007) J Biol Chem 282(45): 32890-901
    › Primary publication · 17848576 (PubMed)
  10. Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Singh AB, Sugimoto K, Dhawan P, Harris RC (2007) Am J Physiol Cell Physiol 293(5): C1660-8
    › Primary publication · 17855771 (PubMed)